TY - JOUR AU - Doble, B. AU - Schofield, D. J. AU - Roscioli, T. AU - Mattick, J. S. PY - 2016 DA - 2016// TI - The promise of personalised medicine JO - Lancet VL - 387 UR - https://doi.org/10.1016/S0140-6736(16)00176-8 DO - 10.1016/S0140-6736(16)00176-8 ID - Doble2016 ER - TY - STD TI - Busse RBM, Scheller-Kreinsen D, Zentner A. Tackling chronic diseases in Europe-strategies, interventions and challenges: observatory studies series no. 20. World Health Organization; 2010. ID - ref2 ER - TY - JOUR AU - Brunner-La Rocca, H. P. AU - Fleischhacker, L. AU - Golubnitschaja, O. AU - Heemskerk, F. AU - Helms, T. AU - Hoedemakers, T. AU - Allianses, S. H. AU - Jaarsma, T. AU - Kinkorova, J. AU - Ramaekers, J. AU - Ruff, P. AU - Schnur, I. AU - Vanoli, E. AU - Verdu, J. AU - Zippel-Schultz, B. PY - 2015 DA - 2015// TI - Challenges in personalised management of chronic diseases-heart failure as prominent example to advance the care process JO - EPMA J VL - 7 UR - https://doi.org/10.1186/s13167-016-0051-9 DO - 10.1186/s13167-016-0051-9 ID - Brunner-La Rocca2015 ER - TY - JOUR AU - Tu, S. M. AU - Bilen, M. A. AU - Tannir, N. M. PY - 2016 DA - 2016// TI - Personalised cancer care: promises and challenges of targeted therapy JO - J R Soc Med VL - 109 UR - https://doi.org/10.1177/0141076816631154 DO - 10.1177/0141076816631154 ID - Tu2016 ER - TY - JOUR AU - Frank, M. AU - Mittendorf, T. PY - 2013 DA - 2013// TI - Influence of pharmacogenomic profiling prior to pharmaceutical treatment in metastatic colorectal cancer on cost effectiveness: a systematic review JO - PharmacoEconomics VL - 31 UR - https://doi.org/10.1007/s40273-012-0017-2 DO - 10.1007/s40273-012-0017-2 ID - Frank2013 ER - TY - JOUR AU - Yang, M. AU - Patel, D. S. AU - Tufail, W. AU - Issa, A. M. PY - 2013 DA - 2013// TI - The quality of economic studies of cancer pharmacogenomics: a quantitative appraisal of the evidence JO - Expert Rev Pharmacoecon Outcomes Res VL - 13 UR - https://doi.org/10.1586/14737167.2013.838023 DO - 10.1586/14737167.2013.838023 ID - Yang2013 ER - TY - JOUR AU - Buxton, M. J. AU - Drummond, M. F. AU - Hout, B. A. AU - Prince, R. L. AU - Sheldon, T. A. AU - Szucs, T. AU - Vray, M. PY - 1997 DA - 1997// TI - Modelling in economic evaluation: an unavoidable fact of life JO - Health Econ VL - 6 UR - https://doi.org/3.0.CO;2-W DO - 3.0.CO;2-W ID - Buxton1997 ER - TY - JOUR AU - Drummond, M. AU - Jonsson, B. AU - Rutten, F. PY - 1997 DA - 1997// TI - The role of economic evaluation in the pricing and reimbursement of medicines JO - Health Policy VL - 40 UR - https://doi.org/10.1016/S0168-8510(97)00901-9 DO - 10.1016/S0168-8510(97)00901-9 ID - Drummond1997 ER - TY - JOUR AU - Sculpher, M. AU - Drummond, M. AU - Buxton, M. PY - 1997 DA - 1997// TI - The iterative use of economic evaluation as part of the process of health technology assessment JO - J Health Serv Res Policy VL - 2 ID - Sculpher1997 ER - TY - JOUR AU - Doble, B. AU - Tan, M. AU - Harris, A. AU - Lorgelly, P. PY - 2015 DA - 2015// TI - Modeling companion diagnostics in economic evaluations of targeted oncology therapies: systematic review and methodological checklist JO - Expert Rev Mol Diagn VL - 15 UR - https://doi.org/10.1586/14737159.2014.929499 DO - 10.1586/14737159.2014.929499 ID - Doble2015 ER - TY - JOUR AU - Moher, D. AU - Liberati, A. AU - Tetzlaff, J. AU - Altman, D. G. AU - Group, P. PY - 2009 DA - 2009// TI - Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement JO - PLoS Med VL - 6 UR - https://doi.org/10.1371/journal.pmed.1000097 DO - 10.1371/journal.pmed.1000097 ID - Moher2009 ER - TY - JOUR AU - Husereau, D. AU - Drummond, M. AU - Petrou, S. AU - Carswell, C. AU - Moher, D. AU - Greenberg, D. AU - Augustovski, F. AU - Briggs, A. H. AU - Mauskopf, J. AU - Loder, E. PY - 2013 DA - 2013// TI - Consolidated Health Economic Evaluation Reporting Standards (CHEERS)–explanation and elaboration: a report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force JO - Value Health VL - 16 UR - https://doi.org/10.1016/j.jval.2013.02.002 DO - 10.1016/j.jval.2013.02.002 ID - Husereau2013 ER - TY - JOUR AU - Welte, R. AU - Feenstra, T. AU - Jager, H. AU - Leidl, R. PY - 2004 DA - 2004// TI - A decision chart for assessing and improving the transferability of economic evaluation results between countries JO - Pharmacoeconomics VL - 22 UR - https://doi.org/10.2165/00019053-200422130-00004 DO - 10.2165/00019053-200422130-00004 ID - Welte2004 ER - TY - JOUR AU - Drummond, M. AU - Barbieri, M. AU - Cook, J. AU - Glick, H. A. AU - Lis, J. AU - Malik, F. AU - Reed, S. D. AU - Rutten, F. AU - Sculpher, M. AU - Severens, J. PY - 2009 DA - 2009// TI - Transferability of economic evaluations across jurisdictions: ISPOR good research practices task force report JO - Value Health VL - 12 UR - https://doi.org/10.1111/j.1524-4733.2008.00489.x DO - 10.1111/j.1524-4733.2008.00489.x ID - Drummond2009 ER - TY - STD TI - https://stats.oecd.org/Index.aspx?DataSetCode=SNA_TABLE4#. UR - https://stats.oecd.org/Index.aspx%3fDataSetCode%3dSNA_TABLE4%23 ID - ref15 ER - TY - JOUR AU - Liberati, A. AU - Altman, D. G. AU - Tetzlaff, J. AU - Mulrow, C. AU - Gotzsche, P. C. AU - Ioannidis, J. P. AU - Clarke, M. AU - Devereaux, P. J. AU - Kleijnen, J. AU - Moher, D. PY - 2009 DA - 2009// TI - The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration JO - BMJ VL - 339 UR - https://doi.org/10.1136/bmj.b2700 DO - 10.1136/bmj.b2700 ID - Liberati2009 ER - TY - JOUR AU - Barzi, A. AU - Sadeghi, S. AU - Kattan, M. W. AU - Meropol, N. J. PY - 2015 DA - 2015// TI - Comparative effectiveness of screening strategies for Lynch syndrome JO - J Natl Cancer Inst ID - Barzi2015 ER - TY - JOUR AU - Gallego, C. J. AU - Shirts, B. H. AU - Bennette, C. S. AU - Guzauskas, G. AU - Amendola, L. M. AU - Horike-Pyne, M. AU - Hisama, F. M. AU - Pritchard, C. C. AU - Grady, W. M. AU - Burke, W. AU - Jarvik, G. P. AU - Veenstra, D. L. PY - 2015 DA - 2015// TI - Next-generation sequencing panels for the diagnosis of colorectal cancer and polyposis syndromes: a cost-effectiveness analysis JO - J Clin Oncol VL - 33 UR - https://doi.org/10.1200/JCO.2014.59.3665 DO - 10.1200/JCO.2014.59.3665 ID - Gallego2015 ER - TY - JOUR AU - Gausachs, M. AU - Mur, P. AU - Corral, J. AU - Pineda, M. AU - Gonzalez, S. AU - Benito, L. AU - Menendez, M. AU - Espinas, J. A. AU - Brunet, J. AU - Iniesta, M. D. AU - Gruber, S. B. AU - Lazaro, C. AU - Blanco, I. AU - Capella, G. PY - 2012 DA - 2012// TI - MLH1 promoter hypermethylation in the analytical algorithm of Lynch syndrome: a cost-effectiveness study JO - Eur J Hum Genet VL - 20 UR - https://doi.org/10.1038/ejhg.2011.277 DO - 10.1038/ejhg.2011.277 ID - Gausachs2012 ER - TY - JOUR AU - Gould-Suarez, M. AU - El-Serag, H. B. AU - Musher, B. AU - Franco, L. M. AU - Chen, G. J. PY - 2014 DA - 2014// TI - Cost-effectiveness and diagnostic effectiveness analyses of multiple algorithms for the diagnosis of Lynch syndrome JO - Dig Dis Sci VL - 59 UR - https://doi.org/10.1007/s10620-014-3248-6 DO - 10.1007/s10620-014-3248-6 ID - Gould-Suarez2014 ER - TY - JOUR AU - Gudgeon, J. M. AU - Williams, J. L. AU - Burt, R. W. AU - Samowitz, W. S. AU - Snow, G. L. AU - Williams, M. S. PY - 2011 DA - 2011// TI - Lynch syndrome screening implementation: business analysis by a healthcare system JO - Am J Manag Care VL - 17 ID - Gudgeon2011 ER - TY - JOUR AU - Leenen, C. H. AU - Goverde, A. AU - Bekker-Grob, E. W. AU - Wagner, A. AU - Lier, M. G. AU - Spaander, M. C. AU - Bruno, M. J. AU - Tops, C. M. AU - Ouweland, A. M. AU - Dubbink, H. J. AU - Kuipers, E. J. AU - Dinjens, W. N. AU - Leerdam, M. E. AU - Steyerberg, E. W. PY - 2016 DA - 2016// TI - Cost-effectiveness of routine screening for Lynch syndrome in colorectal cancer patients up to 70 years of age JO - Genet Med VL - 18 UR - https://doi.org/10.1038/gim.2015.206 DO - 10.1038/gim.2015.206 ID - Leenen2016 ER - TY - JOUR AU - Severin, F. AU - Stollenwerk, B. AU - Holinski-Feder, E. AU - Meyer, E. AU - Heinemann, V. AU - Giessen-Jung, C. AU - Rogowski, W. PY - 2015 DA - 2015// TI - Economic evaluation of genetic screening for Lynch syndrome in Germany JO - Genet Med VL - 17 UR - https://doi.org/10.1038/gim.2014.190 DO - 10.1038/gim.2014.190 ID - Severin2015 ER - TY - JOUR AU - Sie, A. S. AU - Mensenkamp, A. R. AU - Adang, E. M. AU - Ligtenberg, M. J. AU - Hoogerbrugge, N. PY - 2014 DA - 2014// TI - Fourfold increased detection of Lynch syndrome by raising age limit for tumor genetic testing from 50 to 70 years is cost-effective JO - Ann Oncol VL - 25 UR - https://doi.org/10.1093/annonc/mdu361 DO - 10.1093/annonc/mdu361 ID - Sie2014 ER - TY - JOUR AU - Snowsill, T. AU - Huxley, N. AU - Hoyle, M. AU - Jones-Hughes, T. AU - Coelho, H. AU - Cooper, C. AU - Frayling, I. AU - Hyde, C. PY - 2014 DA - 2014// TI - A systematic review and economic evaluation of diagnostic strategies for Lynch syndrome JO - Health Technol Assess VL - 18 UR - https://doi.org/10.3310/hta18580 DO - 10.3310/hta18580 ID - Snowsill2014 ER - TY - JOUR AU - Snowsill, T. AU - Huxley, N. AU - Hoyle, M. AU - Jones-Hughes, T. AU - Coelho, H. AU - Cooper, C. AU - Frayling, I. AU - Hyde, C. PY - 2015 DA - 2015// TI - A model-based assessment of the cost-utility of strategies to identify Lynch syndrome in early-onset colorectal cancer patients JO - BMC Cancer VL - 15 UR - https://doi.org/10.1186/s12885-015-1254-5 DO - 10.1186/s12885-015-1254-5 ID - Snowsill2015 ER - TY - JOUR AU - Dinh, T. A. AU - Rosner, B. I. AU - Atwood, J. C. AU - Boland, C. R. AU - Syngal, S. AU - Vasen, H. F. AU - Gruber, S. B. AU - Burt, R. W. PY - 2011 DA - 2011// TI - Health benefits and cost-effectiveness of primary genetic screening for Lynch syndrome in the general population JO - Cancer Prevent Res VL - 4 UR - https://doi.org/10.1158/1940-6207.CAPR-10-0262 DO - 10.1158/1940-6207.CAPR-10-0262 ID - Dinh2011 ER - TY - JOUR AU - Ladabaum, U. AU - Wang, G. AU - Terdiman, J. AU - Blanco, A. AU - Kuppermann, M. AU - Boland, C. R. AU - Ford, J. AU - Elkin, E. AU - Phillips, K. A. PY - 2011 DA - 2011// TI - Strategies to identify the Lynch syndrome among patients with colorectal cancer: a cost-effectiveness analysis JO - Ann Intern Med VL - 155 UR - https://doi.org/10.7326/0003-4819-155-2-201107190-00002 DO - 10.7326/0003-4819-155-2-201107190-00002 ID - Ladabaum2011 ER - TY - JOUR AU - Wang, G. AU - Kuppermann, M. AU - Kim, B. AU - Phillips, K. A. AU - Ladabaum, U. PY - 2012 DA - 2012// TI - Influence of patient preferences on the cost-effectiveness of screening for lynch syndrome JO - J Oncol Pract VL - 8 UR - https://doi.org/10.1200/JOP.2011.000535 DO - 10.1200/JOP.2011.000535 ID - Wang2012 ER - TY - JOUR AU - Wang, V. W. AU - Koh, P. K. AU - Chow, W. L. AU - Lim, J. F. PY - 2012 DA - 2012// TI - Predictive genetic testing of first degree relatives of mutation carriers is a cost-effective strategy in preventing hereditary non-polyposis colorectal cancer in Singapore JO - Fam Cancer VL - 11 UR - https://doi.org/10.1007/s10689-012-9513-y DO - 10.1007/s10689-012-9513-y ID - Wang2012 ER - TY - JOUR AU - Blank, P. R. AU - Moch, H. AU - Szucs, T. D. AU - Schwenkglenks, M. PY - 2011 DA - 2011// TI - KRAS and BRAF mutation analysis in metastatic colorectal cancer: a cost-effectiveness analysis from a Swiss perspective JO - Clin Cancer Res VL - 17 UR - https://doi.org/10.1158/1078-0432.CCR-10-2267 DO - 10.1158/1078-0432.CCR-10-2267 ID - Blank2011 ER - TY - JOUR AU - Vijayaraghavan, A. AU - Efrusy, M. B. AU - Goke, B. AU - Kirchner, T. AU - Santas, C. C. AU - Goldberg, R. M. PY - 2012 DA - 2012// TI - Cost-effectiveness of KRAS testing in metastatic colorectal cancer patients in the United States and Germany JO - Int J Cancer VL - 131 UR - https://doi.org/10.1002/ijc.26400 DO - 10.1002/ijc.26400 ID - Vijayaraghavan2012 ER - TY - JOUR AU - Behl, A. S. AU - Goddard, K. A. AU - Flottemesch, T. J. AU - Veenstra, D. AU - Meenan, R. T. AU - Lin, J. S. AU - Maciosek, M. V. PY - 2012 DA - 2012// TI - Cost-effectiveness analysis of screening for KRAS and BRAF mutations in metastatic colorectal cancer JO - J Natl Cancer Inst VL - 104 UR - https://doi.org/10.1093/jnci/djs433 DO - 10.1093/jnci/djs433 ID - Behl2012 ER - TY - JOUR AU - Barone, C. AU - Pinto, C. AU - Normanno, N. AU - Capussotti, L. AU - Cognetti, F. AU - Falcone, A. AU - Mantovani, L. PY - 2014 DA - 2014// TI - KRAS early testing: consensus initiative and cost-effectiveness evaluation for metastatic colorectal patients in an Italian setting JO - PLoS ONE VL - 9 UR - https://doi.org/10.1371/journal.pone.0085897 DO - 10.1371/journal.pone.0085897 ID - Barone2014 ER - TY - JOUR AU - Westwood, M. AU - Asselt, T. AU - Ramaekers, B. AU - Whiting, P. AU - Joore, M. AU - Armstrong, N. AU - Noake, C. AU - Ross, J. AU - Severens, J. AU - Kleijnen, J. PY - 2014 DA - 2014// TI - KRAS mutation testing of tumors in adults with metastatic colorectal cancer: a systematic review and cost-effectiveness analysis JO - Health Technol Assess VL - 18 UR - https://doi.org/10.3310/hta18620 DO - 10.3310/hta18620 ID - Westwood2014 ER - TY - JOUR AU - Alberts, S. R. AU - Yu, T. M. AU - Behrens, R. J. AU - Renfro, L. A. AU - Srivastava, G. AU - Soori, G. S. AU - Dakhil, S. R. AU - Mowat, R. B. AU - Kuebler, J. P. AU - Kim, G. P. AU - Mazurczak, M. A. AU - Hornberger, J. PY - 2014 DA - 2014// TI - Comparative economics of a 12-gene assay for predicting risk of recurrence in stage II colon cancer JO - PharmacoEconomics VL - 32 UR - https://doi.org/10.1007/s40273-014-0207-1 DO - 10.1007/s40273-014-0207-1 ID - Alberts2014 ER - TY - JOUR AU - Djalalov, S. AU - Musa, Z. AU - Mendelson, M. AU - Siminovitch, K. AU - Hoch, J. PY - 2011 DA - 2011// TI - A review of economic evaluations of genetic testing services and interventions (2004–2009) JO - Genet Med VL - 13 UR - https://doi.org/10.1097/GIM.0b013e3182003294 DO - 10.1097/GIM.0b013e3182003294 ID - Djalalov2011 ER - TY - JOUR AU - Oosterhoff, M. AU - Maas, M. E. AU - Steuten, L. M. PY - 2016 DA - 2016// TI - A systematic review of health economic evaluations of diagnostic biomarkers JO - Appl Health Econ Health Policy VL - 14 UR - https://doi.org/10.1007/s40258-015-0198-x DO - 10.1007/s40258-015-0198-x ID - Oosterhoff2016 ER - TY - JOUR AU - Wong, W. B. AU - Carlson, J. J. AU - Thariani, R. AU - Veenstra, D. L. PY - 2010 DA - 2010// TI - Cost effectiveness of pharmacogenomics: a critical and systematic review JO - PharmacoEconomics VL - 28 UR - https://doi.org/10.2165/11537410-000000000-00000 DO - 10.2165/11537410-000000000-00000 ID - Wong2010 ER -